200 related articles for article (PubMed ID: 35925576)
1. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria.
Gerber DE; Singh H; Larkins E; Ferris A; Forde PM; Selig W; Basu Roy U
JAMA Oncol; 2022 Sep; 8(9):1333-1339. PubMed ID: 35925576
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
[TBL] [Abstract][Full Text] [Related]
4. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
Lin NU; Prowell T; Tan AR; Kozak M; Rosen O; Amiri-Kordestani L; White J; Sul J; Perkins L; Beal K; Gaynor R; Kim ES
J Clin Oncol; 2017 Nov; 35(33):3760-3773. PubMed ID: 28968165
[TBL] [Abstract][Full Text] [Related]
5. Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
Forde PM; Bonomi P; Shaw A; Blumenthal GM; Ferris A; Patel C; Melemed A; Basu Roy U; Ramamoorthy A; Liu Q; Burns T; Gainor JF; Lovly C; Piotrowska Z; Lehman J; Selig W
Clin Lung Cancer; 2020 Jul; 21(4):295-307. PubMed ID: 32201247
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
Uldrick TS; Ison G; Rudek MA; Noy A; Schwartz K; Bruinooge S; Schenkel C; Miller B; Dunleavy K; Wang J; Zeldis J; Little RF
J Clin Oncol; 2017 Nov; 35(33):3774-3780. PubMed ID: 28968173
[TBL] [Abstract][Full Text] [Related]
8. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
Barry E; Walsh JA; Weinrich SL; Beaupre D; Blasi E; Arenson DR; Jacobs IA
Paediatr Drugs; 2021 Jul; 23(4):381-394. PubMed ID: 34173206
[TBL] [Abstract][Full Text] [Related]
9. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
Spira AI; Stewart MD; Jones S; Chang E; Fielding A; Richie N; Wood LS; Thompson MA; Jones L; Nair A; Mahal BA; Gerber DE
Clin Cancer Res; 2021 May; 27(9):2416-2423. PubMed ID: 33563636
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.
Huang H; Jia S; Wang X; Miao H; Fang H; He H; Wu D; Tang Y; Li N
Thorac Cancer; 2024 May; 15(14):1187-1194. PubMed ID: 38576119
[TBL] [Abstract][Full Text] [Related]
11. Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
Xiao H; Vaidya R; Hershman DL; Unger JM
J Clin Oncol; 2024 Jun; 42(16):1953-1960. PubMed ID: 38537158
[TBL] [Abstract][Full Text] [Related]
12. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
Kim ES; Bruinooge SS; Roberts S; Ison G; Lin NU; Gore L; Uldrick TS; Lichtman SM; Roach N; Beaver JA; Sridhara R; Hesketh PJ; Denicoff AM; Garrett-Mayer E; Rubin E; Multani P; Prowell TM; Schenkel C; Kozak M; Allen J; Sigal E; Schilsky RL
J Clin Oncol; 2017 Nov; 35(33):3737-3744. PubMed ID: 28968170
[TBL] [Abstract][Full Text] [Related]
13. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
Boesen K; Gøtzsche PC; Ioannidis JPA
Epidemiol Psychiatr Sci; 2021 Apr; 30():e35. PubMed ID: 33926608
[TBL] [Abstract][Full Text] [Related]
14. Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration.
Modi ND; Abuhelwa AY; McKinnon RA; Boddy AV; Haseloff M; Wiese MD; Hoffmann TC; Perakslis ED; Rowland A; Sorich MJ; Hopkins AM
JAMA Oncol; 2022 Sep; 8(9):1310-1316. PubMed ID: 35900732
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
16. Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials.
Denicoff AM; Ivy SP; Tamashiro TT; Zhao J; Worthington KH; Mooney MM; Little RF
J Natl Cancer Inst; 2022 Nov; 114(11):1437-1440. PubMed ID: 36047830
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Gan CL; Stukalin I; Meyers DE; Dudani S; Grosjean HAI; Dolter S; Ewanchuk BW; Goutam S; Sander M; Wells C; Pabani A; Cheng T; Monzon J; Morris D; Basappa NS; Pal SK; Wood LA; Donskov F; Choueiri TK; Heng DYC
Eur J Cancer; 2021 Jul; 151():115-125. PubMed ID: 33975059
[TBL] [Abstract][Full Text] [Related]
18. Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer.
Bonomi P; Stuccio N; Delgra CJ; Chuk MK; Spira A; Deitz AC; Blumenthal GM; Ferris A; Gong Y; He J; Basu Roy U; Selig W
Ther Innov Regul Sci; 2020 Sep; 54(5):1208-1214. PubMed ID: 32865803
[TBL] [Abstract][Full Text] [Related]
19. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
20. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
Unger JM; Hershman DL; Fleury ME; Vaidya R
JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
